keyword
https://read.qxmd.com/read/36387107/high-cutoff-hemodialysis-in-multiple-myeloma-patients-with-acute-kidney-injury
#21
REVIEW
Yan Xing, Jipeng Yan, Zixian Yu, Jin Zhao, Yuwei Wang, Xiayin Li, Yunlong Qin, Shiren Sun
Multiple myeloma (MM), an incurable hematological malignancy with clonal proliferation of plasma cells, is mainly characterized by excessive production of monoclonal immunoglobulins and free light chains (FLCs). Kidney injury is one of the main clinical manifestations and is also a significant predictor of the prognosis of symptomatic MM patients, especially those who require dialysis-supported treatment. Overproduction of FLCs is the trigger for kidney injury, as they can induce the transcription of inflammatory and profibrotic cytokines in the proximal tubule and bind to Tamm-Horsfall protein in the distal tubules to form casts that obstruct the tubules, leading to kidney injury and even renal fibrosis...
2022: Frontiers in Oncology
https://read.qxmd.com/read/36328099/light-chain-only-immunotactoid-glomerulopathy-a-case-report
#22
Lihong Bu, Vincent Javaugue, Sophie Chauvet, Jerold Napier, Surendra Dasari, Jason D Theis, Julie A Vrana, Ellen D McPhail, Samih H Nasr
The monotypic variant of immunotactoid glomerulopathy (ITG), strongly associated with low-grade lymphoproliferative disorders, is characterized histologically by glomerulonephritis and microtubular deposits of monoclonal immunoglobulin G (IgG). We report a patient with high-risk κ light chain multiple myeloma who presented with acute kidney injury, hematuria, proteinuria, and hypocomplementemia. Kidney biopsy revealed immunotactoid glomerulopathy concomitant with κ light chain myeloma cast nephropathy...
May 2023: American Journal of Kidney Diseases
https://read.qxmd.com/read/36010261/histological-findings-in-kidney-biopsies-of-patients-with-monoclonal-gammopathy-always-a-surprise
#23
JOURNAL ARTICLE
David Klank, Martin Hoffmann, Stefan Porubsky, Raoul Bergner
Background : The simultaneous occurrence of impaired kidney function and paraproteinemia is common in our constantly aging society. Both can be independent entities; however, renal insufficiency can also be caused by the paraprotein. We assessed all kidney biopsies in patients with monoclonal gammopathy in our clinic over the past 20 years and evaluated the histological results. Methods : Biopsies were systematically performed in nearly all patients with paraproteinemia and impaired kidney function ( n = 178)...
August 7, 2022: Diagnostics
https://read.qxmd.com/read/35964797/clinicopathologic-and-proteomic-characteristics-of-intratubular-cytoplasmic-al-amyloidosis
#24
JOURNAL ARTICLE
Vincent Javaugue, Alejandro Best Rocha, Samar M Said, Dominick Santoriello, Jean Hou, Surendra Dasari, Jason D Theis, Julie A Vrana, Ibrahim Batal, Christopher Larsen, Glen S Markowitz, Vivette D D'Agati, Ellen D McPhail, Nelson Leung, Samih H Nasr
No abstract text is available yet for this article.
October 2022: Kidney International
https://read.qxmd.com/read/35854043/successful-renal-recovery-from-multiple-myeloma-associated-crystalline-light-chain-cast-nephropathy-and-accompanying-acute-kidney-injury-with-early-use-of-bortezomib-based-therapy-a-case-report-and-literature-review
#25
JOURNAL ARTICLE
Kosuke Miki, Yoshinosuke Shimamura, Takuto Maeda, Norihito Moniwa, Yayoi Ogawa, Taku Shimizu, Toshiaki Hayashi, Hajime Sakai, Hideki Takizawa
Crystalline light chain cast nephropathy is a rare distinct morphologic variant of light chain cast nephropathy which is the most common renal lesion associated with multiple myeloma. It is often related to high myeloma tumor burden, severe acute kidney injury, and an unfavorable prognosis. A 79-year-old Japanese man was referred to our medical center with anemia, proteinuria, and acute exacerbation of the serum creatinine accompanying anuria. A renal biopsy showed crystalline cast filling the tubular lumens, injured tubular cells, and inflammatory cells infiltration of interstitium...
July 20, 2022: CEN Case Reports
https://read.qxmd.com/read/35840146/the-use-of-medium-cutoff-dialyzers-in-patients-with-multiple-myeloma-and-acute-kidney-injury-requiring-hemodialysis-a-systematic-review
#26
JOURNAL ARTICLE
Riece Koniman, Su Hooi Teo, Manish Kaushik, Chandramouli Nagarajan, Melinda Si Yun Tan, Han Khim Tan, Maria Erika Gapas Ramirez, Cynthia Ciwei Lim
BACKGROUND: Patients with multiple myeloma and high serum levels of circulating free light chains (FLC) have increased risk of acute kidney injury (AKI) secondary to cast nephropathy and is associated with poor survival. Despite removal of FLC by medium cutoff (MCO) dialyzer, the role of MCO hemodialysis (HD) in the treatment of cast nephropathy and its clinical benefits remain unknown. METHODS: A systematic review was conducted to establish the effectiveness of MCO dialyzer and clinical outcomes, compared to other forms of dialyzers in the removal of FLC, in myeloma patients with AKI...
January 2023: Seminars in Dialysis
https://read.qxmd.com/read/35659060/mono-polyclonal-free-light-chains-as-challenging-biomarkers-for-immunological-abnormalities
#27
JOURNAL ARTICLE
Cecilia Napodano, Krizia Pocino, Francesca Gulli, Elena Rossi, Gian Ludovico Rapaccini, Mariapaola Marino, Umberto Basile
Free light chain (FLC) kappa (k) and lambda (λ) consist of low molecular weight proteins produced in excess during immunoglobulin synthesis and secreted into the circulation. In patients with normal renal function, over 99% of FLCs are filtered and reabsorbed. Thus, the presence of FLCs in the serum is directly related to plasma cell activity and the balance between production and renal clearance. FLCs are bioactive molecules that may exist as monoclonal (m) and polyclonal (p) FLCs. These have been detected in several body fluids and may be key indicators of ongoing damage and/or illness...
2022: Advances in Clinical Chemistry
https://read.qxmd.com/read/35610119/lack-of-renal-recovery-predicts-poor-survival-in-patients-of-multiple-myeloma-with-renal-impairment
#28
JOURNAL ARTICLE
Rintu Sharma, Arihant Jain, Aditya Jandial, Deepesh Lad, Alka Khadwal, Gaurav Prakash, Ritambhra Nada, Ritu Aggarwal, Raja Ramachandran, Neelam Varma, Pankaj Malhotra
BACKGROUND: Renal impairment (RI) confers a poor prognosis in multiple myeloma. Reversibility of renal function is associated with improved survival in such patients. Patients in developing countries often present at an advanced stage and renal impairment is present in up to 40% of patients at diagnosis. We studied the renal outcome and survival of these patients with bortezomib-based induction therapy. MATERIALS AND METHODS: It was a single-center prospective study in a tertiary care multi-specialty institute in patients of newly diagnosed multiple myeloma (NDMM) who presented with RI from July 2018 to December 2019...
August 2022: Clinical Lymphoma, Myeloma & Leukemia
https://read.qxmd.com/read/35592304/light-chain-cast-nephropathy-in-multiple-myeloma-prevalence-impact-and-management-challenges
#29
REVIEW
Paolo Menè, Antonella Stoppacciaro, Silvia Lai, Francescaromana Festuccia
"Cast nephropathy" (CN) is a pathological feature of myeloma kidney, also seen to a lesser extent in the context of severe nephrotic syndrome from non-haematological diseases. The name relates to obstruction of distal tubules by "casts" of luminal proteins concentrated by intensive water reabsorption resulting from dehydration or high-dose diuretics. Filtered proteins form complexes with endogenous tubular Tamm-Horsfall glycoprotein. The resulting gel further slows or stops luminal flow upon complete obstruction of distal convoluted tubules and collecting ducts...
2022: International Journal of Nephrology and Renovascular Disease
https://read.qxmd.com/read/35443439/clinicopathologic-spectrum-of-newly-diagnosed-multiple-myeloma-presenting-with-renal-impairment-a-tertiary-care-center-experience-from-north-india
#30
JOURNAL ARTICLE
S Agarwal
Multiple myeloma (MM) is a hematologic malignancy, characterized by the neoplastic proliferation of plasma cells producing a monoclonal immunoglobulin. Patients presents with signs and symptoms related to the infiltration of plasma cells into the bone or other organs or to kidney damage from excess light chains. Renal involvement with various presentations may be the first manifestation of the disease. MATERIAL: All patients of MM presenting with renal dysfunction between July 2019 to June 2021 were included...
April 2022: Journal of the Association of Physicians of India
https://read.qxmd.com/read/35419374/light-chain-restriction-in-proximal-tubules-implications-for-light-chain-proximal-tubulopathy
#31
JOURNAL ARTICLE
Maike Büttner-Herold, Nathalie Krieglstein, Teresa Chuva, Kaija Minuth, Frederick Pfister, Christoph Daniel, Monika Klewer, Anke Büttner, Fulvia Ferrazzi, Simone Bertz, Kerstin Amann
Monoclonal gammopathy (MG) causes various nephropathies, which may suffice for cytoreductive therapy even in the absence of diagnostic criteria for multiple myeloma or B-cell non-Hodgkin lymphoma. The aim of this study was to better understand the significance of light chain (LC) restriction or crystals (LC-R/C) in proximal tubules in the spectrum of LC-induced nephropathies. A consecutive cohort of 320 renal specimens with a history of B-cell dyscrasia was characterized. Special attention was paid to immunohistochemical LC restriction in proximal tubules, tubular crystals or constipation, and ultrastructural findings...
2022: Frontiers in Medicine
https://read.qxmd.com/read/35371791/multiple-myeloma-and-renal-failure-mechanisms-diagnosis-and-management
#32
REVIEW
Sumana Kundu, Surajkumar B Jha, Ana P Rivera, Gabriela V Flores Monar, Hamza Islam, Sri Madhurima Puttagunta, Rabia Islam, Ibrahim Sange
Multiple myeloma (MM) is the second most common hematologic malignancy that involves monoclonal immunoglobulin (Ig)-producing plasma cells. Due to its multifaceted clinical manifestations and complications, it draws attention to various medical specialties like neurology, nephrology, orthopedics, cardiology, etc. Renal failure (RF) is one of the most common and most serious complications of MM that can be caused either by excess immunoglobulins that are nephrotoxic or some other causes like hypercalcemia, infection, etc...
February 2022: Curēus
https://read.qxmd.com/read/35140519/therapeutic-plasma-exchange-for-cancer-patients
#33
REVIEW
Yuru Hu, Hanshan Yang, Shaozhi Fu, Jingbo Wu
Therapeutic plasma exchange is used as a trial method for the treatment of cancer patients. Therapeutic plasma exchange uses in vitro technology to remove pathogenic factors in the plasma, returning the replacement and remaining components to the patient to facilitate cure. In the effort to explore new methods of cancer treatment, the introduction of therapeutic plasma exchange brings new hope for cancer treatment; however, the current evidence supporting therapeutic plasma exchange is controversial, and most of the evidence comes from observational studies, lacking large prospective randomized trials...
2022: Cancer Management and Research
https://read.qxmd.com/read/35017322/monoclonal-gammopathy-of-renal-significance-spectrum-of-diseases-and-approach-to-a-case
#34
REVIEW
Rohit Tewari, Tathagat Chatterjee, Satish Mendonca, Manu Dogra, Suman Kumar Pramanik, Uday Yanamandra
The occurrence of kidney diseases associated with a monoclonal gammopathy in the absence of symptomatic multiple myeloma is increasingly recognized. When the kidney is involved, the monoclonal etiology of these diseases results in clinical and laboratory features distinct from those of other disease, necessitating the nomenclature monoclonal gammopathy of renal significance (MGRS). The detection of these monoclonal diseases involving the kidney is important since they are poorly responsive to conventional immunosuppression and instead require clone-directed therapy...
March 2021: Saudi Journal of Kidney Diseases and Transplantation
https://read.qxmd.com/read/34982413/management-of-acute-kidney-injury-in-frail-patients-with-biopsy-proven-cast-nephropathy-a-combined-approach-with-chemotherapy-plus-supra-hemodiafiltration-with-post-adsorption-endogenous-reinfusion
#35
JOURNAL ARTICLE
Stefano Murgia, Giacomo Quattrocchio, Giacomo Forneris, Marco Pozzato, Roberta Fenoglio, Michela Ferro, Emanuele De Simone, Giulio Del Vecchio, Carlo Di Benedetto, Dario Roccatello
BACKGROUND: Patients with multiple myeloma often have kidney involvement with acute kidney injury which is frequently due to cast nephropathy. Hemodiafiltration with endogenous reinfusion (HFR) allows removal from the circulation of significant amounts of free light chains (FLCs) responsible for tubular damage. METHODS: Between 2014 and 2018, 13 patients affected by multiple myeloma (64% λ chain and 36% k), including 10 cases with biopsy-proven cast nephropathy, were treated with this technique...
May 2022: Journal of Nephrology
https://read.qxmd.com/read/34980439/-renal-involvement-in-monoclonal-gammopathies
#36
JOURNAL ARTICLE
Jairo Andrés Ibáñez Moreno, Juliana Maria Bacca González, Alejandra Taborda Murillo, Sigifredo Ospina Ospina, Luis Fernando Arias
INTRODUCTION: The kidney is one of the organs most frequently affected by disease processes which produce monoclonal immunoglobins, therefore renal morphological and immunopathological alterations should be clearly recognized. OBJECTIVE: To describe the pathological features of renal involvement in monoclonal gammopathies. MATERIAL AND METHODS: A descriptive, retrospective and cross-sectional study of renal biopsies studied in a single center during a period of 14 years was carried out...
2022: Revista Española de Patología
https://read.qxmd.com/read/34868773/a-case-of-cast-nephropathy-found-as-the-cause-of-severe-renal-failure
#37
Gen Adachi, Naoto Mouri, Ryuichi Ohta, Chiak Sano
Cast nephropathy is rare kidney disease with slow progression. It is associated with multiple myeloma (MM). In this study, we report a case of cast nephropathy in an 86-year-old woman who was previously independent in her activities of daily living (ADLs). However, she was found to have severe renal impairment after vomiting and a decrease in her ADLs. Blood and urine tests revealed the renal disorder. The patient was immediately treated with hemodiafiltration. IgG, IgA, and IgM levels were decreased by immunoelectrophoresis...
October 2021: Curēus
https://read.qxmd.com/read/34767832/the-characteristics-of-patients-with-kidney-light-chain-deposition-disease-concurrent-with-light-chain-amyloidosis
#38
JOURNAL ARTICLE
Samar M Said, Alejandro Best Rocha, Anthony M Valeri, Paisit Paueksakon, Surendra Dasari, Jason D Theis, Julie A Vrana, Modupe O Obadina, Darius Saghafi, Mariam Priya Alexander, Sanjeev Sethi, Christopher P Larsen, Florent Joly, Angela Dispenzieri, Frank Bridoux, Christophe Sirac, Nelson Leung, Agnes B Fogo, Ellen D McPhail, Samih H Nasr
The type of monoclonal light chain nephropathy is thought to be largely a function of the structural and physiochemical properties of light chains; hence most affected patients have only one light chain kidney disease type. Here, we report the first series of kidney light chain deposition disease (LCDD) concomitant with light chain amyloidosis (LCDD+AL), with or without light chain cast nephropathy (LCCN). Our LCDD+AL cohort consisted of 37 patients (54% females, median age 70 years (range 40-86)). All cases showed Congo red-positive amyloid deposits staining for one light chain isotype on immunofluorescence (62% lambda), and LCDD with diffuse linear staining of glomerular and tubular basement membranes for one light chain isotype (97% same isotype as the amyloidogenic light chain) and ultrastructural non-fibrillar punctate deposits...
January 2022: Kidney International
https://read.qxmd.com/read/34692330/unusual-case-of-nephrotic-syndrome-from-light-chain-amyloidosis-in-a-37-year-old-patient
#39
Omar K Salameh, Matthew C Darok, Jennifer A Kane, Catherine Abendroth, Naman Trivedi
Amyloidosis with renal involvement is a well-known cause of nephrotic syndrome. Immunoglobulin light-chain amyloidosis (AL), which is a result of monoclonal light-chain deposition in the kidney from plasma cell dyscrasia, is rare before the age of 40 and typically occurs in old patients. Most cases of renal amyloidosis in young patients are secondary to chronic inflammatory disease. We are reporting a case of a 37-year-old male who was transferred to our hospital for evaluation of possibly acquired bleeding disorder...
September 2021: Curēus
https://read.qxmd.com/read/34651090/iga-nephropathy-in-igg-kappa-multiple-myeloma
#40
JOURNAL ARTICLE
Maria Eduarda Couto, Domingos Sousa, Hugo Ferreira, Alda Tavares, Isabel Oliveira, Nelson Domingues, Ana Paiva, Teresa Chuva, José Maximino, Rui Manuel Ferreira Henrique, José Mário Mariz
Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studies did not show criteria for MM progression or other causes. This case highlights the need for further investigation of kidney injury in MM patients (such as toxicity of previous drugs, infectious events, or immune-mediated disorders).
September 2021: Porto Biomedical Journal
keyword
keyword
120978
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.